BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: May RM, Cassol C, Hannoudi A, Larsen CP, Lerma E, Haun RS, Braga JR, Hassen SI, Wilson J, VanBeek C, Vankalakunti M, Barnum L, Walker PD, Bourne TD, Messias NC, Ambruzs JM, Boils CL, Sharma SS, Cossey LN, Baxi PV, Palmer M, Zuckerman J, Walavalkar V, Urisman A, Gallan A, Al-Rabadi LF, Rodby R, Luyckx V, Espino G, Santhana-Krishnan S, Alper B, Lam SG, Hannoudi GN, Matthew D, Belz M, Singer G, Kunaparaju S, Price D, Sauabh C, Rondla C, Abdalla MA, Britton ML, Paul S, Ranjit U, Bichu P, Williamson SR, Sharma Y, Gaspert A, Grosse P, Meyer I, Vasudev B, El Kassem M, Velez JCQ, Caza TN. A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19). Kidney Int 2021:S0085-2538(21)00734-1. [PMID: 34352311 DOI: 10.1016/j.kint.2021.07.015] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Gnanenthiran SR, Borghi C, Burger D, Caramelli B, Charchar F, Chirinos JA, Cohen JB, Cremer A, Di Tanna GL, Duvignaud A, Freilich D, Gommans DHF, Gracia-Ramos AE, Murray TA, Pelorosso F, Poulter NR, Puskarich MA, Rizas KD, Rothlin R, Schlaich MP, Schreinlecher M, Steckelings UM, Sharma A, Stergiou GS, Tignanelli CJ, Tomaszewski M, Unger T, van Kimmenade RRJ, Wainford RD, Williams B, Rodgers A, Schutte AE; COVID‐METARASI Consortium. Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension. J Am Heart Assoc 2022;:e026143. [PMID: 36000426 DOI: 10.1161/JAHA.122.026143] [Reference Citation Analysis]
2 Geetha D, Kronbichler A, Rutter M, Bajpai D, Menez S, Weissenbacher A, Anand S, Lin E, Carlson N, Sozio S, Fowler K, Bignall R, Ducharlet K, Tannor EK, Wijewickrama E, Hafiz MIA, Tesar V, Hoover R, Crews D, Varnell C, Danziger-Isakov L, Jha V, Mohan S, Parikh C, Luyckx V. Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions. Nat Rev Nephrol 2022. [PMID: 36002770 DOI: 10.1038/s41581-022-00618-4] [Reference Citation Analysis]
3 Xia Y, Coates PT, Nangaku M. How does diabetes cause susceptibility to COVID-19 in the kidney: new clues provided by organoids. Kidney Int 2022:S0085-2538(22)00608-1. [PMID: 35963447 DOI: 10.1016/j.kint.2022.07.016] [Reference Citation Analysis]
4 Lucas A, Wyatt CM. HIV at 40: Kidney Disease in HIV Treatment, Prevention, and Cure. Kidney Int 2022:S0085-2538(22)00533-6. [PMID: 35850290 DOI: 10.1016/j.kint.2022.06.021] [Reference Citation Analysis]
5 Gómez Preciado F, De Carvalho Ovalles RA, Codina S, Donadeu L, Favà A, Martinez Valenzuela L, Sandoval D, Fernández-cidón B, Bestard O, Alia-ramos P, Gomà M, Melilli E, Cruzado JM. Collapsing Glomerulonephritis in a Kidney Transplant Recipient after mRNA SARS-CoV-2 Vaccination. JCM 2022;11:3651. [DOI: 10.3390/jcm11133651] [Reference Citation Analysis]
6 Papalia G, Barbuto S, Campus A, Vischini G. Double glomerulopathies or two-faced janus? A challenging case in the COVID-19 era. J Nephrol 2022. [PMID: 35666373 DOI: 10.1007/s40620-022-01351-8] [Reference Citation Analysis]
7 Savedchuk S, Raslan R, Nystrom S, Sparks MA. Emerging Viral Infections and the Potential Impact on Hypertension, Cardiovascular Disease, and Kidney Disease. Circ Res 2022;130:1618-41. [PMID: 35549373 DOI: 10.1161/CIRCRESAHA.122.320873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fahim P, Nicolaysen A, Yabu JM, Zuckerman JE. Osmotic Tubulopathy and Acute Thrombotic Microangiopathy in a Kidney Transplant Recipient With a Breakthrough COVID-19 Infection. Kidney Medicine 2022. [DOI: 10.1016/j.xkme.2022.100492] [Reference Citation Analysis]
9 Mahalingasivam V, Su G, Iwagami M, Davids MR, Wetmore JB, Nitsch D. COVID-19 and kidney disease: insights from epidemiology to inform clinical practice. Nat Rev Nephrol 2022. [PMID: 35418695 DOI: 10.1038/s41581-022-00570-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lodi L, Mastrolia MV, Bello F, Rossi GM, Angelotti ML, Crow YJ, Romagnani P, Vaglio A. Type I interferon-related kidney disorders. Kidney Int 2022:S0085-2538(22)00213-7. [PMID: 35339535 DOI: 10.1016/j.kint.2022.02.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Hassler L, Batlle D. Potential SARS-CoV-2 kidney infection and paths to injury. Nat Rev Nephrol. [DOI: 10.1038/s41581-022-00551-6] [Reference Citation Analysis]
12 Nomura E, Finn LS, Bauer A, Rozansky D, Iragorri S, Jenkins R, Al-Uzri A, Richardson K, Wright M, Kung VL, Troxell ML, Andeen NK. Pathology findings in pediatric patients with COVID-19 and kidney dysfunction. Pediatr Nephrol 2022. [PMID: 35166918 DOI: 10.1007/s00467-022-05457-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gambella A, Barreca A, Biancone L, Roccatello D, Peruzzi L, Besso L, Licata C, Attanasio A, Papotti M, Cassoni P. Spectrum of Kidney Injury Following COVID-19 Disease: Renal Biopsy Findings in a Single Italian Pathology Service. Biomolecules 2022;12:298. [DOI: 10.3390/biom12020298] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hung AM, Shah SC, Bick AG, Yu Z, Chen HC, Hunt CM, Wendt F, Wilson O, Greevy RA, Chung CP, Suzuki A, Ho YL, Akwo E, Polimanti R, Zhou J, Reaven P, Tsao PS, Gaziano JM, Huffman JE, Joseph J, Luoh SW, Iyengar S, Chang KM, Casas JP, Matheny ME, O'Donnell CJ, Cho K, Tao R, Susztak K, Robinson-Cohen C, Tuteja S, Siew ED; VA Million Veteran Program COVID-19 Science Initiative. APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program. JAMA Intern Med 2022. [PMID: 35089317 DOI: 10.1001/jamainternmed.2021.8538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
15 Caza TN, Al-Rabadi LF, Beck LH Jr. How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy. Front Immunol 2021;12:800242. [PMID: 34899763 DOI: 10.3389/fimmu.2021.800242] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Caza TN, Cassol CA, Messias N, Hannoudi A, Haun RS, Walker PD, May RM, Seipp RM, Betchick EJ, Amin H, Ziadie MS, Haderlie M, Eduwu-Okwuwa J, Vancea I, Seek M, Elashi EB, Shenoy G, Khalillullah S, Flaxenburg JA, Brandt J, Diamond MJ, Frome A, Kim EH, Schlessinger G, Ulozas E, Weatherspoon JL, Hoerschgen ET, Fabian SL, Bae SY, Iqbal B, Chouhan KK, Karam Z, Henry JT, Larsen CP. Glomerular Disease in Temporal Association with SARS-CoV-2 Vaccination: A Series of 29 Cases. Kidney360 2021;2:1770-80. [PMID: 35372991 DOI: 10.34067/KID.0005372021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
17 Long JD, Strohbehn I, Sawtell R, Bhattacharyya R, Sise ME. COVID-19 Survival and its impact on chronic kidney disease. Transl Res 2021:S1931-5244(21)00266-8. [PMID: 34774843 DOI: 10.1016/j.trsl.2021.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
18 Wu J, Ma Z, Raman A, Beckerman P, Dhillon P, Mukhi D, Palmer M, Chen HC, Cohen CR, Dunn T, Reilly J, Meyer N, Shahaty M, Arany Z, Haskó G, Laudanski K, Hung A, Susztak K. APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis. Immunity 2021;54:2632-2649.e6. [PMID: 34715018 DOI: 10.1016/j.immuni.2021.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wu J, Raman A, Coffey NJ, Sheng X, Wahba J, Seasock MJ, Ma Z, Beckerman P, Laczkó D, Palmer MB, Kopp JB, Kuo JJ, Pullen SS, Boustany-Kari CM, Linkermann A, Susztak K. The key role of NLRP3 and STING in APOL1-associated podocytopathy. J Clin Invest 2021;131:e136329. [PMID: 34651582 DOI: 10.1172/JCI136329] [Cited by in F6Publishing: 9] [Reference Citation Analysis]